Print this page |
|
Below table shows the anticancer properties of various kinds of mushrooms.
Source: the Faculty of Medicine, the University of Tokyo, the National Cancer Center Research Center and the Tokyo University of Pharmacy. |
|
|
Name of mushroom
|
Dosage/kg/Day
|
Rate of complete recovery
|
Anticancer effect
|
|
|
Agaricus blazei Murill |
10mg |
90.0% |
99.4% |
|
|
|
Grifola umbellata |
10mg |
90.0% |
98.5% |
|
|
|
Phellinus yucatensis |
30mg |
87.5% |
96.5% |
|
|
|
Phellinus igniarius |
30mg |
66.7% |
87.4% |
|
|
|
Lenxites betulina |
30mg |
57.1% |
70.2% |
|
|
|
Tricholoma matsutake |
30mg |
55.5% |
91.3% |
|
|
|
Lentinus edodes |
30mg |
54.5% |
80.7% |
|
|
|
Coriolus versicolor |
30mg |
50.0% |
77.5% |
|
|
|
Pleurotus osteatus |
30mg |
45.5% |
75.3% |
|
|
|
Elfringia applanata |
30mg |
45.5% |
64.9% |
|
|
|
Fomitopsis pincicola |
30mg |
33.3% |
61.2% |
|
|
|
Fomitopsis cytisna |
30mg |
30.3% |
44.2% |
|
|
|
Pholiota nameko |
30mg |
30.0% |
86.5% |
|
|
|
Flammulina velutipes |
30mg |
30.0% |
81.1% |
|
|
|
Ganoderma lucidum |
30mg |
20.0% |
77.8% |
|
|
|
|
Copyright © 2013 Healfinity Pharmaceutical. All rights reserved.
|